{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:01:43Z","timestamp":1793289703892,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["06171956"],"award-info":[{"award-number":["06171956"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1053\/j.gastro.2020.03.074","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T23:46:21Z","timestamp":1586303181000},"page":"609-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"title":["Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice"],"prefix":"10.1053","volume":"159","author":[{"given":"David Kung-Chun","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Wai-Hin","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinth Wing-Sum","family":"Cheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2845-1562","authenticated-orcid":false,"given":"Vox","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fehlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermi","family":"Sumatoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Nardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan W.","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Oi-Lin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Chung-Cheung","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ming","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Chak-Lui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2020.03.074_bib1","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"10027","key":"10.1053\/j.gastro.2020.03.074_bib2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2020.03.074_bib3","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 4","key":"10.1053\/j.gastro.2020.03.074_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1634\/theoncologist.2010-S4-42","article-title":"Treatment of intermediate\/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?","volume":"15","author":"Lencioni","year":"2010","journal-title":"Oncologist"},{"issue":"10064","key":"10.1053\/j.gastro.2020.03.074_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"issue":"10126","key":"10.1053\/j.gastro.2020.03.074_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"10088","key":"10.1053\/j.gastro.2020.03.074_bib7","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2020.03.074_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1053\/j.gastro.2020.03.074_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1189\/jlb.72.3.486","article-title":"Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells","volume":"72","author":"Imaizumi","year":"2002","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1053\/j.gastro.2020.03.074_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.it.2016.10.002","article-title":"TIGIT: a key inhibitor of the cancer immunity cycle","volume":"38","author":"Manieri","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1053\/j.gastro.2020.03.074_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/JID.2015.404","article-title":"Melanoma cells control antimelanoma CTL responses via interaction between TIGIT and CD155 in the effector phase","volume":"136","author":"Inozume","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1053\/j.gastro.2020.03.074_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41467-018-08096-8","article-title":"Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice","volume":"10","author":"Zong","year":"2019","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2020.03.074_bib13","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.30467","article-title":"Induction of oxidative stress through inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2020.03.074_bib14","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2020.03.074_bib15","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1158\/1078-0432.CCR-16-2677","article-title":"Timing of PD-1 blockade is critical to effective combination immunotherapy with anti-OX40","volume":"23","author":"Messenheimer","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2020.03.074_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma","volume":"8","author":"Chiu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2020.03.074_bib17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cell.2014.05.051","article-title":"p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer","volume":"158","author":"Tschaharganeh","year":"2014","journal-title":"Cell"},{"key":"10.1053\/j.gastro.2020.03.074_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","volume":"37","author":"Becht","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1053\/j.gastro.2020.03.074_bib19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"issue":"1\u20132","key":"10.1053\/j.gastro.2020.03.074_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","article-title":"Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"key":"10.1053\/j.gastro.2020.03.074_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3799","article-title":"Balancing natural killer cell activation through paired receptors","volume":"15","author":"Martinet","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.gastro.2020.03.074_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1083\/jcb.200501090","article-title":"Inhibition of cell movement and proliferation by cell-cell contact-induced interaction of Necl-5 with nectin-3","volume":"171","author":"Fujito","year":"2005","journal-title":"J\u00a0Cell Biol"},{"key":"10.1053\/j.gastro.2020.03.074_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/d41573-019-00182-w","article-title":"Trends in clinical development for PD-1\/PD-L1 inhibitors","volume":"19","author":"Xin Yu","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1053\/j.gastro.2020.03.074_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2020.03.074_bib25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s12094-018-02011-9","article-title":"The role of immunotherapy in small cell lung cancer","volume":"21","author":"Calles","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1053\/j.gastro.2020.03.074_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2249.2004.02478.x","article-title":"Differential expression of CTLA-4 among T cell subsets","volume":"136","author":"Jago","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1053\/j.gastro.2020.03.074_bib27","doi-asserted-by":"crossref","first-page":"E221","DOI":"10.1073\/pnas.1208573110","article-title":"CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire","volume":"110","author":"Verhagen","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2020.03.074_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"10.1053\/j.gastro.2020.03.074_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"10.1053\/j.gastro.2020.03.074_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","article-title":"The immunoreceptor TIGIT regulates antitumor and antiviral CD8+ T cell effector function","volume":"26","author":"Johnston","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1053\/j.gastro.2020.03.074_bib31","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.1003081","article-title":"Cutting edge: TIGIT has T cell-intrinsic inhibitory functions","volume":"186","author":"Joller","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1053\/j.gastro.2020.03.074_bib32","article-title":"TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM","volume":"7","author":"Hung","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1053\/j.gastro.2020.03.074_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/2326-6066.CIR-18-0351","article-title":"TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma","volume":"7","author":"Josefsson","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1053\/j.gastro.2020.03.074_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1053\/j.gastro.2020.03.074_bib35","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00262-017-2031-x","article-title":"Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions","volume":"66","author":"Xu","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/j.gastro.2020.03.074_bib36","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1053\/j.gastro.2020.03.074_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1086862","article-title":"Tumor-intrinsic oncogene pathways mediating immune avoidance","volume":"5","author":"Spranger","year":"2016","journal-title":"Oncoimmunology"},{"issue":"7128","key":"10.1053\/j.gastro.2020.03.074_bib38","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature05529","article-title":"Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas","volume":"445","author":"Xue","year":"2007","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2020.03.074_bib39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ni.2850","article-title":"The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions","volume":"15","author":"Chan","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1053\/j.gastro.2020.03.074_bib40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/2326-6066.CIR-18-0637","article-title":"CD96 is an immune checkpoint that regulates CD8+ T-cell antitumor function","volume":"7","author":"Mittal","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1053\/j.gastro.2020.03.074_bib41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/2326-6066.CIR-18-0442","article-title":"PVRIG and PVRL2 are induced in cancer and inhibit CD8+ T-cell function","volume":"7","author":"Whelan","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1053\/j.gastro.2020.03.074_bib42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hep.30347","article-title":"Human CD96 correlates to natural killer cell exhaustion and predicts the prognosis of human hepatocellular carcinoma","volume":"70","author":"Sun","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2020.03.074_bib43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/PPO.0000000000000185","article-title":"Immune checkpoint therapy and the search for predictive biomarkers","volume":"22","author":"Sharma","year":"2016","journal-title":"Cancer J"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508520304613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508520304613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:05:40Z","timestamp":1777421140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508520304613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0016508520304613"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2020.03.074","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2020.03.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}